The presentation will include recent comments by MCA and FDA on the use of criminal supply chains and how to spot them.
The presentation will review the current situation of recent recalls by small firms. The presentation will cover how to establish good supply chain procedures and what to seek in such a system.
The presentation will include FDAs recent guidance document on supply chain for Compounding Pharmacies and how others can use these same standards.
Why you should Attend: Why attend? The major reason for small pharmaceutical companies to enter into a recall situation is the poor quality of raw materials and active ingredients.
Currently, we face issues with generic drug supplies where carcinogens appear in our blood pressure medications, affecting millions of us.
Compounding pharmacies, generic firms, and small pharmaceutical companies struggle with adequate and compliant supply chain. In addition, many firms suffer from the criminal suppliers. Both MCA and FDA warn firms about the potential use.
Areas Covered in the Session:
Criminals in Supply Chain Management
FDA and MCA comments on criminal activities
Recent Recalls due to lack of supply chain management
Proper testing requirements
How to avoid a recall due to supply chain
Who Will Benefit:
- Regulatory Affairs
- Supply Chain
• Regulatory Affairs
• Supply Chain